8 terminated. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 1 | 2 | Terminated 2 |
Follow Immunoenzyme Techniques: new trials by email Literature Review of Immunoenzyme Techniques trials Research Report on Immunoenzyme Techniques
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases paricalcitol, immunoenzyme technique, laboratory biomarker analysis - Metastatic Cancer, Prostate Cancer | Phase 2 | Terminated | Wake Forest University Health Sciences | 2 | 2009-01-01 | 2018-07-06 |
| Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery cetuximab, carboplatin, cisplatin - Head and Neck Cancer | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 47 | 2008-02-01 | 2018-07-09 |
| Dasatinib in Treating Patients With Stage IV Pancreatic Cancer dasatinib, immunoenzyme technique, immunohistochemistry staining method - Pancreatic Cancer | Phase 2 | Terminated | City of Hope Medical Center | 7 | 2007-09-01 | 2015-10-05 |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission sorafenib tosylate, immunoenzyme technique, immunohistochemistry staining method - Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 6 | 2007-07-01 | 2016-02-29 |
| Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery defined green tea catechin extract, placebo, immunohistochemistry staining method - Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 2 | Terminated | Case Comprehensive Cancer Center | 5 | 2006-10-01 | 2012-03-15 |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 29 | 2006-03-01 | 2015-04-01 |
| Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma PS-341 (VELCADE), temozolomide, immunoenzyme technique - Brain and Central Nervous System Tumors, Melanoma | Phase 1 / Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 47 | 2003-06-01 | 2012-10-02 |
| Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma filgrastim, dexrazoxane hydrochloride, doxorubicin hydrochloride - Sarcoma | Phase 2 | Terminated | City of Hope Medical Center | 7 | 2001-08-01 | 2014-08-28 |
Prostatic Neoplasms (2) · Sarcoma (2) · Brain Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Central Nervous System Neoplasms (1) · Fallopian Tube Neoplasms (1) · Head and Neck Neoplasms (1) · Liposarcoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
City of Hope Medical Center (3) · Case Comprehensive Cancer Center (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Memorial Sloan Kettering Cancer Center (1) · Vanderbilt-Ingram Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (6) · Belgium (1)
Gary G. Schwartz, MD, PhD, MPH (1) · Jan B. Vermorken, MD, PhD (1) · Jeffrey A. Sosman, MD (1) · Mebea Aklilu, MD (1) · Paul Sabbatini, MD (1) · Sanjay Gupta (1) · Vincent Chung, MD (1) · Warren A. Chow, MD (1) · Warren Chow (1) · William P. Tew, MD (1)
P30CA033572 (2), P30CA008748 (1), P30CA012197 (1)